FI895681A0 - Farmaceutisk komposition foer systemisk transdermal tillfoersel. - Google Patents
Farmaceutisk komposition foer systemisk transdermal tillfoersel.Info
- Publication number
- FI895681A0 FI895681A0 FI895681A FI895681A FI895681A0 FI 895681 A0 FI895681 A0 FI 895681A0 FI 895681 A FI895681 A FI 895681A FI 895681 A FI895681 A FI 895681A FI 895681 A0 FI895681 A0 FI 895681A0
- Authority
- FI
- Finland
- Prior art keywords
- tillfoersel
- systemisk
- foer
- transdermal
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888807504A GB8807504D0 (en) | 1988-03-29 | 1988-03-29 | Improvements in/relating to organic compounds |
PCT/EP1989/000291 WO1989009051A1 (en) | 1988-03-29 | 1989-03-18 | Deprenyl for systemic transdermal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
FI895681A0 true FI895681A0 (fi) | 1989-11-28 |
Family
ID=10634325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI895681A FI895681A0 (fi) | 1988-03-29 | 1989-11-28 | Farmaceutisk komposition foer systemisk transdermal tillfoersel. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0404807B1 (hu) |
JP (1) | JP2533211B2 (hu) |
KR (1) | KR0136870B1 (hu) |
AU (1) | AU630088B2 (hu) |
CA (1) | CA1336071C (hu) |
DE (1) | DE68907406T2 (hu) |
ES (1) | ES2013129A6 (hu) |
FI (1) | FI895681A0 (hu) |
GB (1) | GB8807504D0 (hu) |
GR (1) | GR1003711B (hu) |
HU (1) | HU207441B (hu) |
IE (1) | IE62955B1 (hu) |
IL (1) | IL89748A (hu) |
MY (1) | MY105121A (hu) |
NZ (1) | NZ228467A (hu) |
PT (1) | PT90120B (hu) |
WO (1) | WO1989009051A1 (hu) |
ZA (1) | ZA892321B (hu) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4861800A (en) * | 1987-08-18 | 1989-08-29 | Buyske Donald A | Method for administering the drug deprenyl so as to minimize the danger of side effects |
HU209605B (en) * | 1991-04-15 | 1994-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of wather-free transdermal preparation |
EP0593807A1 (en) * | 1992-10-22 | 1994-04-27 | LTS Lohmann Therapie-Systeme GmbH & Co. KG | Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation |
HUT63579A (en) * | 1991-12-20 | 1993-09-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes |
US5242950A (en) * | 1992-04-23 | 1993-09-07 | Somerset Pharmaceuticals, Inc. | Treatment of macular degeneration |
ES2164286T3 (es) * | 1993-04-20 | 2002-02-16 | Hexal Ag | Emplasto con sustancias activas. |
PT762877E (pt) * | 1994-06-03 | 2001-08-30 | Thejmde Trust | Arilalquilaminas meta-substituidas e suas aplicacoes terapeuticas e de diagnostico |
HU223475B1 (hu) * | 1994-10-24 | 2004-07-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására |
US6299901B1 (en) | 1995-01-13 | 2001-10-09 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
US6348208B1 (en) | 1995-01-13 | 2002-02-19 | Somerset Pharmaceuticals, Inc. | Methods and pharmaceutical compositions employing desmethylselegiline |
US6033682A (en) | 1995-01-13 | 2000-03-07 | Somerset Pharmaceuticals, Inc. | S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions |
US6319954B1 (en) | 1995-01-13 | 2001-11-20 | Somerset Pharmaceuticals, Inc. | S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions |
NZ309980A (en) | 1995-06-07 | 2001-06-29 | Noven Pharma | Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
DE19533089C1 (de) | 1995-09-07 | 1997-05-22 | Hexal Ag | Tacrin-Pflaster |
DE19533772C1 (de) * | 1995-09-12 | 1998-01-02 | Hexal Ag | Tacrin/Selegilin-Pflaster |
IL119417A (en) * | 1996-10-13 | 2003-02-12 | Moshe Kushnir | Pharmaceutical composition for transdermal administration of levodopa for parkinson's disease |
US7150881B2 (en) | 1997-06-26 | 2006-12-19 | Mylan Technologies, Inc. | Adhesive mixture for transdermal delivery of highly plasticizing drugs |
BR9908713A (pt) | 1998-03-16 | 2000-11-21 | Somerset Pharmaceuticals Inc | Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos |
DE19814257A1 (de) | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
AU778992B2 (en) † | 1998-12-07 | 2004-12-23 | Agi Therapeutics Research Limited | Transdermal patch for delivering volatile liquid drugs |
ATE427745T1 (de) | 2001-11-05 | 2009-04-15 | Krele Pharmaceuticals Llc | Zusammensetzungen und verfahren zur erhíhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus |
DE10338174A1 (de) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
SG157415A1 (en) | 2004-11-23 | 2009-12-29 | Adamas Pharmaceuticals Inc | Composition comprising a sustained release coating or matrix and an nmda receptor antagonist, method for administration such nmda antagonist to a subject |
WO2006121560A2 (en) | 2005-04-06 | 2006-11-16 | Adamas Pharmaceuticals, Inc. | Methods and compositions for treatment of cns disorders |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
US7846445B2 (en) | 2005-09-27 | 2010-12-07 | Amunix Operating, Inc. | Methods for production of unstructured recombinant polymers and uses thereof |
CA2690945C (en) * | 2007-06-21 | 2015-07-21 | Fujimoto Co., Ltd. | Transdermal or transmucosal pharmaceutical composition comprising 1-(benzofuran-2-yl)-2-propylaminopentane |
JP2010536341A (ja) | 2007-08-15 | 2010-12-02 | アムニクス, インコーポレイテッド | 生物学的に活性なポリペプチドの特性を改変するための組成物および方法 |
EP2393828B1 (en) | 2009-02-03 | 2016-10-12 | Amunix Operating Inc. | Extended recombinant polypeptides and compositions comprising same |
MX354555B (es) | 2009-06-08 | 2018-03-09 | Amunix Operating Inc | Polipeptidos de la hormona de crecimiento y metodos de preparacion y su uso. |
EP2440228B8 (en) | 2009-06-08 | 2023-02-22 | Amunix Operating Inc. | Glucose-regulating polypeptides and methods of making and using same |
WO2011028229A1 (en) | 2009-08-24 | 2011-03-10 | Amunix Operating Inc. | Coagulation factor ix compositions and methods of making and using same |
BR112012013487A2 (pt) | 2009-12-02 | 2017-10-03 | Adamas Pharmaceuticals Inc | Composições de amantadina e métodos de uso |
DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
RS63870B1 (sr) | 2012-02-15 | 2023-01-31 | Bioverativ Therapeutics Inc | Sastavi faktora viii i postupci za pravljenje i upotrebu istih |
HUE043537T2 (hu) | 2012-02-15 | 2019-08-28 | Bioverativ Therapeutics Inc | Rekombináns VIII faktor fehérjék |
US10154971B2 (en) | 2013-06-17 | 2018-12-18 | Adamas Pharma, Llc | Methods of administering amantadine |
US10548953B2 (en) | 2013-08-14 | 2020-02-04 | Bioverativ Therapeutics Inc. | Factor VIII-XTEN fusions and uses thereof |
EP3331608A4 (en) | 2015-08-03 | 2019-05-01 | Bioverativ Therapeutics Inc. | FUSION XI FUSION PROTEINS AND METHODS OF MAKING AND USING THE SAME |
WO2018071656A1 (en) | 2016-10-14 | 2018-04-19 | Knowles Enterprises Inc. | Formulations for treatment of migraines |
WO2018200885A1 (en) | 2017-04-26 | 2018-11-01 | Neurocentria, Inc. | Magnesium compositions and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0139127A1 (en) * | 1983-08-22 | 1985-05-02 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Transdermal drug delivery device and its preparation |
IL72684A (en) * | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
US4568343A (en) * | 1984-10-09 | 1986-02-04 | Alza Corporation | Skin permeation enhancer compositions |
EP0241809B1 (de) * | 1986-04-16 | 1990-08-08 | ASTA Pharma Aktiengesellschaft | Synergistische Kombination von Amantadin und Selegilin |
-
1988
- 1988-03-29 GB GB888807504A patent/GB8807504D0/en active Pending
-
1989
- 1989-03-18 AU AU32900/89A patent/AU630088B2/en not_active Expired
- 1989-03-18 EP EP89903719A patent/EP0404807B1/en not_active Revoked
- 1989-03-18 DE DE89903719T patent/DE68907406T2/de not_active Revoked
- 1989-03-18 WO PCT/EP1989/000291 patent/WO1989009051A1/en not_active Application Discontinuation
- 1989-03-18 JP JP1503424A patent/JP2533211B2/ja not_active Expired - Lifetime
- 1989-03-18 HU HU892559A patent/HU207441B/hu unknown
- 1989-03-23 NZ NZ228467A patent/NZ228467A/en unknown
- 1989-03-23 IE IE92189A patent/IE62955B1/en not_active IP Right Cessation
- 1989-03-27 IL IL89748A patent/IL89748A/xx unknown
- 1989-03-27 PT PT90120A patent/PT90120B/pt not_active IP Right Cessation
- 1989-03-27 GR GR890100190A patent/GR1003711B/el not_active IP Right Cessation
- 1989-03-28 MY MYPI89000387A patent/MY105121A/en unknown
- 1989-03-29 ES ES8901101A patent/ES2013129A6/es not_active Expired - Lifetime
- 1989-03-29 CA CA000595075A patent/CA1336071C/en not_active Expired - Fee Related
- 1989-03-29 ZA ZA892321A patent/ZA892321B/xx unknown
- 1989-11-28 KR KR1019890702205A patent/KR0136870B1/ko not_active IP Right Cessation
- 1989-11-28 FI FI895681A patent/FI895681A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MY105121A (en) | 1994-08-30 |
IE890921L (en) | 1989-09-29 |
NZ228467A (en) | 1991-12-23 |
PT90120B (pt) | 1994-06-30 |
EP0404807B1 (en) | 1993-06-30 |
DE68907406T2 (de) | 1993-10-14 |
HU207441B (en) | 1993-04-28 |
AU3290089A (en) | 1989-10-16 |
KR0136870B1 (ko) | 1998-04-25 |
DE68907406D1 (de) | 1993-08-05 |
ZA892321B (en) | 1990-12-28 |
JPH02503677A (ja) | 1990-11-01 |
HU892559D0 (en) | 1990-01-28 |
ES2013129A6 (es) | 1990-04-16 |
HUT55220A (en) | 1991-05-28 |
AU630088B2 (en) | 1992-10-22 |
JP2533211B2 (ja) | 1996-09-11 |
GB8807504D0 (en) | 1988-05-05 |
IL89748A (en) | 1993-07-08 |
EP0404807A1 (en) | 1991-01-02 |
KR900700089A (ko) | 1990-08-11 |
PT90120A (pt) | 1989-11-10 |
GR1003711B (el) | 2001-10-25 |
WO1989009051A1 (en) | 1989-10-05 |
GR890100190A (el) | 1990-01-19 |
CA1336071C (en) | 1995-06-27 |
IE62955B1 (en) | 1995-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI895681A0 (fi) | Farmaceutisk komposition foer systemisk transdermal tillfoersel. | |
DE68901417D1 (de) | Pharmazeutische zusammensetzung. | |
FI901102A0 (fi) | Farmaceutiska kompositioner. | |
FI922364A0 (fi) | Farmaceutiska kompositioner. | |
DE68907659D1 (de) | Warmhaertende organosiloxanzusammensetzung. | |
DK229489D0 (da) | Laegemiddeladsorbater | |
SE8801813D0 (sv) | Pharmaceutical composition | |
KR890701101A (ko) | 제약학적 조성물 | |
FI893643A0 (fi) | Farmaceutiska kompositioner. | |
NO882653D0 (no) | Doseringsform. | |
IT8820386A0 (it) | Composizioni farmaceutiche orosolubili contenti acetilcisteina. | |
DE68916395D1 (de) | Zusammensetzung. | |
FI872733A (fi) | Farmaceutiska kompositioner. | |
DE68907177D1 (de) | Dosierungsform. | |
FI872313A (fi) | Farmaceutiska kompositioner. | |
FI883673A0 (fi) | Farmaceutiska kompositioner. | |
IT1213453B (it) | Composizione farmaceutica. | |
DE68906193D1 (de) | Hypersphyxia verursachende zusammensetzung. | |
FI874414A0 (fi) | Kontrollerat frigoerande farmaceutiska kompositioner. | |
DE68903729D1 (de) | Tertiaere thiolaethoxylat-zusammensetzung. | |
DE68907609D1 (de) | Arzneimittelzusammensetzung. | |
FI892552A0 (fi) | Benzoyl- och ketonperoxidkomposition. | |
ATE78161T1 (de) | 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung. | |
DE3888800D1 (de) | Transdermales Arzneimittelpräparat. | |
IT1224244B (it) | Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused | ||
FC | Application refused |
Owner name: SOMERSET PHARMACEUTICALS, INC. |